Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

EHA 2019

All Publications

Treatment with Imetelstat Provides Durable Transfusion Independence in Heavily Transfused Non-del(5q) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents

Clinical Imetelstat: MDS Imetelstat

Fenaux, P, et al.

Favorable Overall Survival of Imetelstat-treated Relapsed/Refractory Myelofibrosis Patients Compared with Closely Matched Real World Data

Clinical Imetelstat: MF Imetelstat

Kuykendall, A, et al.

[facetwp facet="publication_load_more"]